Drug Approval | April 21, 2026
Orbicular's partner secures tentative U.S. ANDA approval for a generic version of Ozempic
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
OneSource is the contract development and manufacturing organization (CDMO) partner for this product
Shift from approvals to digital intimation via NSWS portal aims to cut timelines and boost innovation in early-stage drug development
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
The conclave brought together key stakeholders from across the assisted living ecosystem
SBE303 targets Nectin-4, an adhesion protein overexpressed in multiple tumor types, including urothelial, lung, and breast cancers
These tests deliver results in 10–15 minutes at a cost of Rs 100–Rs 150, compared to conventional diagnostics which cost up to Rs 15,000
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
AI-enabled learning platform to enhance clinical quality, patient outcomes, and staff engagement across Eastern India network
The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools
The litigation involved multiple civil lawsuits alleging anti-competitive practices and violations of federal
Subscribe To Our Newsletter & Stay Updated
